Sylvie Dinh

Sylvie Dinh currently serves as Senior Manager of Financial Planning and Analysis (FP&A) at BridgeBio, a biopharmaceutical company focused on developing treatments for genetic diseases and cancers. Prior to this role, Sylvie held positions as FP&A Manager at Exym and in various finance and accounting roles at ASG, Aimmune Therapeutics, Cleave Therapeutics, and CH Reynolds, culminating in experience as Lead Staff Accountant. Sylvie holds a Bachelor's Degree in Business Administration with a focus on Accounting from San Jose State University.